Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia

Maria P. Caraceni, Enzo Corghi, Sergio Ortolani, Silvano Casazza, Alberto D'Alberton, Tiziano Motta

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P

Original languageEnglish
Pages (from-to)687-689
Number of pages3
JournalCalcified Tissue International
Volume37
Issue number6
DOIs
Publication statusPublished - Nov 1985

Fingerprint

Hyperprolactinemia
Bromocriptine
Dopamine Agonists
Forearm
Prolactin
Bone Density
Pharmacology
Therapeutics

Keywords

  • Bone mineral content
  • Bromocriptine
  • Hyperprolactinemia

ASJC Scopus subject areas

  • Endocrinology
  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia. / Caraceni, Maria P.; Corghi, Enzo; Ortolani, Sergio; Casazza, Silvano; D'Alberton, Alberto; Motta, Tiziano.

In: Calcified Tissue International, Vol. 37, No. 6, 11.1985, p. 687-689.

Research output: Contribution to journalArticle

Caraceni, Maria P. ; Corghi, Enzo ; Ortolani, Sergio ; Casazza, Silvano ; D'Alberton, Alberto ; Motta, Tiziano. / Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia. In: Calcified Tissue International. 1985 ; Vol. 37, No. 6. pp. 687-689.
@article{ffc140335994474a9d089da1f0c05261,
title = "Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia",
abstract = "We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P",
keywords = "Bone mineral content, Bromocriptine, Hyperprolactinemia",
author = "Caraceni, {Maria P.} and Enzo Corghi and Sergio Ortolani and Silvano Casazza and Alberto D'Alberton and Tiziano Motta",
year = "1985",
month = "11",
doi = "10.1007/BF02554932",
language = "English",
volume = "37",
pages = "687--689",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia

AU - Caraceni, Maria P.

AU - Corghi, Enzo

AU - Ortolani, Sergio

AU - Casazza, Silvano

AU - D'Alberton, Alberto

AU - Motta, Tiziano

PY - 1985/11

Y1 - 1985/11

N2 - We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P

AB - We studied 15 hyperprolactinemic women to evaluate possible modifications of bone mineral content after pharmacological treatment. Patients received a dopamine agonist (bromocriptine) for six months after which there was a significant decrease of prolactin plasma levels (P

KW - Bone mineral content

KW - Bromocriptine

KW - Hyperprolactinemia

UR - http://www.scopus.com/inward/record.url?scp=0022388621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022388621&partnerID=8YFLogxK

U2 - 10.1007/BF02554932

DO - 10.1007/BF02554932

M3 - Article

VL - 37

SP - 687

EP - 689

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 6

ER -